Physiologically Based Pharmacokinetic Modeling to Understand the Observed Drug–Drug Interaction of LY2623091 with CYP3A Inhibitors Itraconazole and Diltiazem
International Journal of Pharmacokinetics · 2017
DOI: 10.4155/ipk-2017-0005 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmacokinetics, 2017. Verfasst von Gemma L Dickinson und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Eli Lilly and Company, inVentiv Health Clinical.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Eli Lilly and Company
- inVentiv Health Clinical
Zitieren
APA
Dickinson, G. L., Phillips, D. L., Posada, M. M., Chaudhary, A., & Hall, S. D. (2017). Physiologically Based Pharmacokinetic Modeling to Understand the Observed Drug–Drug Interaction of LY2623091 with CYP3A Inhibitors Itraconazole and Diltiazem. International Journal of Pharmacokinetics. https://doi.org/10.4155/ipk-2017-0005
Vancouver
Dickinson GL, Phillips DL, Posada MM, Chaudhary A, Hall SD. Physiologically Based Pharmacokinetic Modeling to Understand the Observed Drug–Drug Interaction of LY2623091 with CYP3A Inhibitors Itraconazole and Diltiazem. International Journal of Pharmacokinetics. 2017. doi:10.4155/ipk-2017-0005
BibTeX
@article{Dickinson2017,
author = {Dickinson, Gemma L and Phillips, Diane L and Posada, Maria M and Chaudhary, Archana and Hall, Stephen D},
title = {Physiologically Based Pharmacokinetic Modeling to Understand the Observed Drug–Drug Interaction of LY2623091 with CYP3A Inhibitors Itraconazole and Diltiazem},
journal = {International Journal of Pharmacokinetics},
year = {2017},
doi = {10.4155/ipk-2017-0005}
}
EUVIMED